Acute myeloid leukemia with e1a2 BCR-ABL1 fusion gene: two cases with peculiar molecular and clinical presentations

Acute myeloid leukemia with e1a2 BCR-ABL1 fusion gene: two cases with peculiar molecular and clinical presentations

Bibliographic Details
Main Authors:	Fernanda Borges da Silva, João Agostinho Machado-Neto, Luisa Corrêa de Araujo Koury, Virginia Helena Leira Lipoli Bertini, Cristina Alonso Ratis, Maria de Lourdes Lopes Ferrari Chauffaille, Elvira Deolinda Rodrigues Pereira Velloso, Belinda Pinto Simões, Eduardo Magalhães Rego, Fabiola Traina
Format:	Article
Language:	English
Published:	Elsevier
Series:	Revista Brasileira de Hematologia e Hemoterapia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842017000400379&lng=en&tlng=en

Similar Items

The other Achilles’ heel of BCR-ABL1
by: Kim De Keersmaecker
Published: (2012-01-01)

No Benefit of BCR-ABL1 Screening in Polycythemia
by: STEPHEN E. LANGABEER
Published: (2016-07-01)

Fluorescent in-situ hybridization (FISH) for BCR/ABL in chronic myeloid leukemia after bone marrow transplantation
by: Maria de Lourdes Lopes Ferrari Chauffaille, et al.
Published: (2001-01-01)

Detection of ABL1 deletion without BCR-ABL rearrangement in ETP-ALL
by: Ahmed Makboul, et al.
Published: (2024-10-01)

A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias
by: Oksana Montecchini, et al.
Published: (2021-11-01)

Association between the BCR-ABL gene transcripts and the laboratory hematological profile
by: Marcelo Braga de Oliveira, et al.
Published: (2022-09-01)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
by: Mian Afsar, et al.
Published: (2012-09-01)

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
by: Saskia Maletzke, et al.
Published: (2022-01-01)

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia.
by: Saskia Maletzke, et al.
Published: (2022-01-01)

New ABL1 Kinase Domain Mutations in BCR::ABL1‐Positive Acute Lymphoblastic Leukemia
by: Zixuan Li, et al.
Published: (2024-10-01)

Precision Medicine in BCR-ABL1 Negative Myeloproliferative Neoplasms
by: Linet Njue, et al.
Published: (2020-12-01)

Sphingomyelin synthase 1 activity is regulated by the BCR-ABL oncogene[S]
by: Tara Ann Burns, et al.
Published: (2013-03-01)

Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations
by: Benedetta Mariotti, et al.
Published: (2019-01-01)

A double Philadelphia chromosome-positive chronic myeloid leukemia patient, co-expressing P210BCR-ABL1 and P195BCR-ABL1 isoforms
by: Raquel Vinhas, et al.
Published: (2018-11-01)

FISH mapping of Philadelphia negative <it>BCR/ABL1 </it>positive CML
by: Marin David, et al.
Published: (2008-07-01)

Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.
by: Foroni, L, et al.
Published: (2011)

Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia
by: Zhanglin Zhang, et al.
Published: (2019-10-01)

NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE
by: Gianfranco Catalano, et al.
Published: (2020-10-01)

Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells
by: Shohei Kawakami, et al.
Published: (2022-01-01)

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK
by: Cross, N, et al.
Published: (2018)

OCT-1 function varies with cell lineage but is not influenced by BCR-ABL
by: Jane R. Engler, et al.
Published: (2011-02-01)

Targeting BCR-ABL1-positive leukaemias: a review article
by: Steven Leak, et al.
Published: (2023-01-01)

Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India
by: Nikhil Rabade, et al.
Published: (2018-01-01)

Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
by: Asako Takeuchi, et al.
Published: (2021-01-01)

Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms
by: Moysés Antonio Porto-Soares, et al.
Published: (2020-07-01)

FREQUÊNCIA DE MUTAÇÕES ENCONTRADAS NO NEOGENE BCR::ABL1 EM PACIENTES BRASILEIROS, DIAGNOSTICADOS COM LEUCEMIA MIELOIDE CRÔNICA
by: LC Loyola, et al.
Published: (2023-10-01)

Monitoring BCR-ABL transcript levels by real-time quantitative polymerase chain reaction: a linear regression equation to convert from BCR-ABL/B2M ratio to estimated BCR-ABL/ABL ratio
by: Ilaria Iacobucci, et al.
Published: (2007-03-01)

Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells
by: Chengwu Zeng, et al.
Published: (2024-10-01)

A Novel BCR::ABL1 Variant Detected with Multiple Testing Modalities
by: J. Jean, et al.
Published: (2024-01-01)

Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia
by: matteo molica, et al.
Published: (2020-08-01)

Development of mirror-image monobodies targeting the oncogenic BCR::ABL1 kinase
by: Nina Schmidt, et al.
Published: (2024-12-01)

Identification of rare atypical BCR-ABL1 transcript: A case report
by: Jayesh Saha, et al.
Published: (2023-07-01)

PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOID LEUKEMIA WITH BCR::ABL1 FUSION
by: MCS Sousa, et al.
Published: (2024-10-01)

Phosphorylation of BECLIN-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia
by: Chuanjiang Yu, et al.
Published: (2020-05-01)

BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
by: Gunnar Cario, et al.
Published: (2020-05-01)

BCR::ABL1-negative myeloproliferative neoplasms in the era of next-generation sequencing
by: Aleksandra Mroczkowska-Bękarciak, et al.
Published: (2023-09-01)

Leukemia: Reduction Ratio and Halving Time of BCR: : ABL1 IS Transcript Levels
by: Funda Ceran, et al.
Published: (2022-08-01)

Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
by: Haruka Hiroki, et al.
Published: (2023-05-01)

A kinase-independent role for CDK8 in BCR-ABL1+ leukemia
by: Ingeborg Menzl, et al.
Published: (2019-10-01)

p210BCR‐ABL1‐ Chronic myeloid leukemia presents with monocytosis
by: Xiaofei Wang, et al.
Published: (2020-05-01)